176 related articles for article (PubMed ID: 33156532)
1. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L
Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532
[TBL] [Abstract][Full Text] [Related]
2. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
[TBL] [Abstract][Full Text] [Related]
4. [The importance of HE4 in differential diagnosis of endometrial cancer].
Minář L; Klabenešová I; Jandáková E
Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413
[TBL] [Abstract][Full Text] [Related]
5. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
[TBL] [Abstract][Full Text] [Related]
6. Preoperative markers for the prediction of high-risk features in endometrial cancer.
Panyavaranant P; Manchana T
World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
[TBL] [Abstract][Full Text] [Related]
7. Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus.
Moore RG; Miller CM; Brown AK; Robison K; Steinhoff M; Lambert-Messerlian G
Int J Gynecol Cancer; 2011 Oct; 21(7):1185-90. PubMed ID: 21720250
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
9. The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.
Atguden Z; Yildiz A; Aksut H; Yalcin SE; Yalcin Y; Uysal D; Yetimalar H
Asian Pac J Cancer Prev; 2016; 17(2):497-501. PubMed ID: 26925634
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study.
Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G
Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834
[TBL] [Abstract][Full Text] [Related]
11. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.
Kalogera E; Scholler N; Powless C; Weaver A; Drapkin R; Li J; Jiang SW; Podratz K; Urban N; Dowdy SC
Gynecol Oncol; 2012 Feb; 124(2):270-5. PubMed ID: 22037318
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
Prueksaritanond N; Cheanpracha P; Yanaranop M
Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.
Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F
Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710
[TBL] [Abstract][Full Text] [Related]
16. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
[TBL] [Abstract][Full Text] [Related]
17. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.
Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P
Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397
[TBL] [Abstract][Full Text] [Related]
18. Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kinalski M; Terlikowski SJ
Adv Med Sci; 2016 Mar; 61(1):23-7. PubMed ID: 26344910
[TBL] [Abstract][Full Text] [Related]
19. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.
Omer B; Genc S; Takmaz O; Dirican A; Kusku-Kiraz Z; Berkman S; Gurdol F
Tumour Biol; 2013 Oct; 34(5):2645-50. PubMed ID: 23640061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
